MULTIPLE CTL SPECIFICITIES AGAINST AUTOLOGOUS HIV-1-INFECTED BLCLS

被引:6
作者
AHEARNE, PM
MORGAN, RA
SEBASTIAN, MW
BOLOGNESI, DP
WEINHOLD, KJ
机构
[1] DUKE UNIV, MED CTR, DEPT SURG, DURHAM, NC 27710 USA
[2] NHLBI, MOLEC HEMATOL BRANCH, BETHESDA, MD 20892 USA
关键词
D O I
10.1006/cimm.1995.1006
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The cellular immune response to HIV-1 has been well studied but, in many respects, remains incompletely defined. Although CTL specificities against highly conserved HIV-1 determinants as dictated by vaccinia/HIV-1 vector constructs have been described, much less is known regarding patient cellular reactivities against autologous cells infected with HIV-1. One of the main obstacles in characterizing this cellular reactivity has been the absence of a targeting system which accurately represents the HIV infected cell in vivo and is, at the same time, adaptable for in vitro assays. Through the use of two separate strategies aimed at increasing cellular CD4 expression, we were able to infect B-lymphocyte cell lines (BLCLs) with multiple strains of HIV-1. HIV-1-infected BLCLs were recognized by autologous effector cells with cytolytic specificities against env, gag, or pol determinants. In addition, HIV-1-infected BLCLs were capable of eliciting in vitro CTL reactivities directed against env-, gag-, and pol-expressing targets. This cellular reactivity was mediated by CD8(+) cells and was MHC Class I restricted, suggesting a classical CTL response. Since multiple antigens are recognized, an HIV-1-infected BLCL is a more natural representation of an in vivo cellular target than other available testing systems and should permit a more representative analysis of CTL responses during infection or following vaccination. (C) 1995 Academic Press, Inc.
引用
收藏
页码:34 / 41
页数:8
相关论文
共 19 条
[1]  
AUTRAN B, 1988, AIDS, V2, P179
[2]  
BENNINK JR, 1990, CURR TOP MICROBIOL, V163, P153
[3]   EFFECTS OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) ON THE CYTO-TOXIC RESPONSE TO EPSTEIN-BARR VIRUS (EBV) TRANSFORMED LYMPHOCYTE-B [J].
BLUMBERG, RS ;
PARADIS, TJ ;
CRAWFORD, D ;
BYINGTON, RE ;
HIRSCH, MS ;
SCHOOLEY, RT .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1987, 3 (03) :303-315
[4]   EXPRESSION OF HERPES-SIMPLEX VIRUS-1 GLYCOPROTEIN-B BY A RECOMBINANT VACCINIA VIRUS AND PROTECTION OF MICE AGAINST LETHAL HERPES-SIMPLEX VIRUS-1 INFECTION [J].
CANTIN, EM ;
EBERLE, R ;
BALDICK, JL ;
MOSS, B ;
WILLEY, DE ;
NOTKINS, AL ;
OPENSHAW, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (16) :5908-5912
[5]   DIFFERENCES AMONG HUMAN IMMUNODEFICIENCY VIRUS-STRAINS IN THEIR CAPACITIES TO INDUCE CYTOLYSIS OR PERSISTENT INFECTION OF A LYMPHOBLASTOID CELL-LINE IMMORTALIZED BY EPSTEIN-BARR-VIRUS [J].
DAHL, K ;
MARTIN, K ;
MILLER, G .
JOURNAL OF VIROLOGY, 1987, 61 (05) :1602-1608
[6]   INFECTION OF EPSTEIN-BARR VIRUS-TRANSFORMED LYMPHOBLASTOID B-CELLS BY THE HUMAN-IMMUNODEFICIENCY-VIRUS - EVIDENCE FOR A PERSISTENT AND PRODUCTIVE INFECTION LEADING TO B-CELL PHENOTYPIC CHANGES [J].
DEROSSI, A ;
RONCELLA, S ;
CALABRO, ML ;
DANDREA, E ;
PASTI, M ;
PANOZZO, M ;
MAMMANO, F ;
FERRARINI, M ;
CHIECOBIANCHI, L .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (09) :2041-2049
[7]  
HOFFENBACH A, 1989, J IMMUNOL, V142, P452
[8]   COMPLEMENT AND ANTIBODY MEDIATE ENHANCEMENT OF HIV-INFECTION BY INCREASING VIRUS BINDING AND PROVIRUS FORMATION [J].
JUNE, RA ;
SCHADE, SZ ;
BANKOWSKI, MJ ;
KUHNS, M ;
MCNAMARA, A ;
LINT, TF ;
LANDAY, AL ;
SPEAR, GT .
AIDS, 1991, 5 (03) :269-274
[9]   INDUCTION OF EPSTEIN-BARR VIRUS IN B-LYMPHOBLASTOID CELLS BY HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 [J].
LAI, PK ;
LI, X ;
VOLSKY, DJ .
INTERNATIONAL JOURNAL OF CANCER, 1989, 43 (06) :1104-1111
[10]   AIDS-ASSOCIATED RETROVIRUSES (ARV) CAN PRODUCTIVELY INFECT OTHER CELLS BESIDES HUMAN T-HELPER CELLS [J].
LEVY, JA ;
SHIMABUKURO, J ;
MCHUGH, T ;
CASAVANT, C ;
STITES, D ;
OSHIRO, L .
VIROLOGY, 1985, 147 (02) :441-448